Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
576.49
-7.21 (-1.24%)
At close: Dec 3, 2025, 4:00 PM EST
577.00
+0.51 (0.09%)
Pre-market: Dec 4, 2025, 7:04 AM EST
Medpace Holdings Stock Forecast
Stock Price Forecast
The 11 analysts that cover Medpace Holdings stock have a consensus rating of "Hold" and an average price target of $465.18, which forecasts a -19.31% decrease in the stock price over the next year. The lowest target is $305 and the highest is $655.
Price Target: $465.18 (-19.31%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Medpace Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 9 | 7 | 7 | 8 | 7 | 8 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 2 | 2 | 2 | 2 | 2 |
| Total | 11 | 10 | 10 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Hold Initiates $600 | Hold | Initiates | $600 | +4.08% | Nov 13, 2025 |
| TD Cowen | TD Cowen | Strong Sell Maintains $356 → $462 | Strong Sell | Maintains | $356 → $462 | -19.86% | Oct 24, 2025 |
| Barclays | Barclays | Sell Maintains $425 → $485 | Sell | Maintains | $425 → $485 | -15.87% | Oct 24, 2025 |
| Mizuho | Mizuho | Buy Maintains $575 → $655 | Buy | Maintains | $575 → $655 | +13.62% | Oct 24, 2025 |
| Mizuho | Mizuho | Buy Maintains $510 → $575 | Buy | Maintains | $510 → $575 | -0.26% | Oct 17, 2025 |
Financial Forecast
Revenue This Year
2.56B
from 2.11B
Increased by 21.48%
Revenue Next Year
2.87B
from 2.56B
Increased by 11.90%
EPS This Year
15.09
from 12.63
Increased by 19.47%
EPS Next Year
16.72
from 15.09
Increased by 10.83%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.7B | 3.0B | ||||
| Avg | 2.6B | 2.9B | ||||
| Low | 2.5B | 2.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 26.0% | 17.4% | ||||
| Avg | 21.5% | 11.9% | ||||
| Low | 16.2% | 4.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.70 | 18.03 | ||||
| Avg | 15.09 | 16.72 | ||||
| Low | 14.41 | 14.64 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 24.3% | 19.5% | ||||
| Avg | 19.5% | 10.8% | ||||
| Low | 14.1% | -3.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.